Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Filings indexed 1,660 across all filing types
Latest filing 2022-05-06 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, as amended, we wish to inform you that the audio recordings ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the availability of audio recordings of an 'Analyst/Investor Conference Call' for Q4 FY 22 results. It references the SEBI Listing Obligations and Disclosure Requirements and provides a URL to the audio recording. The document does not contain the transcript itself, financial data, or detailed analysis, but rather announces the availability of the call recording. Given the content and length (1614 characters), this is an announcement related to a conference call, not the call transcript itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the call recording availability.
2022-05-06 English
General updates
Regulatory Filings
2022-05-05 English
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, please ....
Regulatory Filings
2022-05-05 English
Please find enclosed press release on the financial performance of the Company for the quarter and financial year ended 31st March 2022 with the title - 'Morepen Labs Annual FY22 Revenue ....
Regulatory Filings
2022-05-05 English
Please find enclosed the Investors Presentation (Q4'FY22) May, 2022, based on the financial performance of the Company for the quarter and financial year ended 31st March, 2022.
Regulatory Filings
2022-05-05 English
Investor Presentation
Regulatory Filings
2022-05-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.